PITTSBURGH — Generic drug maker Mylan has appointed Jacek Glinka as president of its European division, the company said Thursday.
Glinka's appointment becomes effective Dec. 2. Before joining Mylan, he was CEO of Polpharma Group from 2003 to 2006 and again from 2009 until this year, helping the company expand from a small, local company to a leading drug company in central and eastern Europe, the Caucasus and Central Asia. The company became a leader in the Polish market and doubled its sales to more than $1 billion between 2011 and 2013.
"[Jacek's] exceptional track record leading Polpharma speaks for itself, and we believe his deep experience in the region will contribute to Mylan's continued success and growth in Europe," Mylan CEO Heather Bresch said. "We believe Jacek's strong leadership, strategic thinking and operational discipline will build on the solid foundation and leadership team we already have in place and maximize the many opportunities we see ahead for our European business."